US 11219621
Methods for treating immunodeficiency disease
granted A61KA61K31/395A61K31/4709
Quick answer
US patent 11219621 (Methods for treating immunodeficiency disease) held by X4 Pharmaceuticals, Inc. expires Mon Jan 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- X4 Pharmaceuticals, Inc.
- Grant date
- Tue Jan 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/395, A61K31/4709, A61K9/0053, A61K9/485